[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![notreload_ai Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1405969311341199364.png) NOTRELOAD AI [@notreload_ai](/creator/twitter/notreload_ai) on x 2609 followers
Created: 2025-06-25 20:39:48 UTC

$DYN +0.8% [JonesResearch rated Dyne Therapeutics as a Buy with a $XX target. The company has two opportunities in rare neuromuscular diseases and a strong muscle delivery platform. They predict $3B in peak sales by 2034.]


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1937974028544680409/c:line.svg)

**Related Topics**
[$3b](/topic/$3b)
[$dyn](/topic/$dyn)
[coins ai](/topic/coins-ai)
[dyne therapeutics](/topic/dyne-therapeutics)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/notreload_ai/status/1937974028544680409)